Discloses the difference between actual results and the prior mid-year forecast for the 2026 interim period. Revenue exceeded the forecast, but profits declined due to yen depreciation and bidding effects. The full-year forecast keeps revenue unchanged, but lowers operating income, ordinary income, and net income attributable to owners of the parent.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"5187","jir_company_name":"Create Medic Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/5187-20260805-02.pdf","jir_short_summary":"Discloses the difference between actual results and the prior mid-year forecast for the 2026 interim period. Revenue exceeded the forecast, but profits declined due to yen depreciation and bidding effects. The full-year forecast keeps revenue unchanged, but lowers operating income, ordinary income, and net income attributable to owners of the parent.","jir_summary":"### Performance comparison\nDomestic sales remained solid, but profitability deteriorated due to the impact of centralized purchases in China tied to bidding and a sharp yen depreciation, resulting in interim cumulative operating income, ordinary income, and net income attributable to owners of the parent below the previous forecast. On the other hand, revenue exceeded the forecast. The full-year forecast is expected to keep revenue unchanged, but operating income, ordinary income, and net income attributable to owners of the parent are lowered.\n\n### Outlook and risks\nThe full-year consolidated earnings forecast may change depending on future business environment, exchange rate movements, and bidding conditions, and the revisions are based on information currently available. It notes that actual results may differ from the forecast due to future factors.","jir_financial_highlights":"Revenue: 6,932 \u767e\u4e07\u5186 (Compared with the previous forecast of 6,630 \u767e\u4e07\u5186, +302 \u767e\u4e07\u5186 (4.6% increase))\nOperating income: 336 \u767e\u4e07\u5186 (Compared with the previous forecast of 510 \u767e\u4e07\u5186, \u25b3174 \u767e\u4e07\u5186 (approximately \u25b334.0%))\nOrdinary income: 398 \u767e\u4e07\u5186 (Compared with the previous forecast of 510 \u767e\u4e07\u5186, \u25b3112 \u767e\u4e07\u5186 (approximately \u25b321.9%))\nNet income attributable to owners of the parent (Interim]: 260 \u767e\u4e07\u5186 (Compared with the previous forecast of 357 \u767e\u4e07\u5186, \u25b397 \u767e\u4e07\u5186 (approximately \u25b327.1%))\nBasic earnings per share (Interim): 31.63 \u5186 (Compared with the previous forecast of 42.58 \u5186, \u25b310.95 \u5186)","jir_category":"","jir_hashtags":"#CreateMedicCoLtd, #financial_summary, #JapanStocks","jir_key_figures":"Revenue: 6,932 \u767e\u4e07\u5186\uff08\u5b9f\u7e3e\uff09\nOperating income: 336 \u767e\u4e07\u5186\uff08\u5b9f\u7e3e\uff09\nOrdinary income: 398 \u767e\u4e07\u5186\uff08\u5b9f\u7e3e\uff09\nNet income attributable to owners of the parent: 260 \u767e\u4e07\u5186\nBasic earnings per share: 31.63 \u5186","jir_meta_title":"\u3010Create Medic Co., Ltd.\u30112026 Interim Earnings Forecast Revisions \/ Actual Result Gaps | Revenue Stables, but Profit Forecast Revised Downward","jir_meta_description":"Summary of Create Medic's 2026 interim results vs. prior forecast and revisions to full-year guidance. Domestic sales solid, but profit margins eroded by yen depreciation and bidding; full-year operating income, ordinary income, and net income revised downward. See IR materials for details.","jir_og_title":"\u3010Create Medic\u3011Notice of Interim Earnings Forecast Revision","jir_og_description":"Summary of Create Medic's 2026 interim results and revisions to full-year forecast. Revenue beat expectations, but profits decreased. Explanations of outlook and risks.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59045,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-95491","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n